Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$289.9
Market cap
$155.83B
P/E Ratio
36.74
Dividend/share
$9
EPS
$7.89
Enterprise value
$207.22B
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
Highlights
Amgen's equity has increased by 27% from the previous quarter
The revenue has grown by 21% year-on-year and by 5% since the previous quarter
AMGN's quick ratio has dropped by 67% year-on-year but it is up by 7% since the previous quarter
The P/E is 55% above the 5-year quarterly average of 23.6 but 7% below the last 4 quarters average of 39.4
AMGN's gross margin is down by 18% year-on-year and by 4.4% since the previous quarter
Key stats
What are the main financial stats of AMGN
Market
Valuations
Earnings
Shares outstanding
537.53M
Market cap
$155.83B
Enterprise value
$207.22B
Price to earnings (P/E)
36.74
Price to book (P/B)
20.7
Price to sales (P/S)
4.79
EV/EBIT
26.2
EV/EBITDA
15.37
EV/Sales
6.37
Revenue
$32.53B
EBIT
$7.91B
EBITDA
$13.48B
Free cash flow
$6.28B
Per share
Balance sheet
Liquidity
EPS
$7.89
Free cash flow per share
$11.7
Book value per share
$14.01
Revenue per share
$60.58
TBVPS
$80.64
Total assets
$90.88B
Total liabilities
$83.36B
Debt
$60.4B
Equity
$7.53B
Working capital
$6.45B
Debt to equity
8.02
Current ratio
1.32
Quick ratio
0.8
Net debt/EBITDA
3.81
Margins
Efficiency
Dividend
EBITDA margin
41.4%
Gross margin
60.5%
Net margin
13%
Operating margin
19.1%
Return on assets
4.5%
Return on equity
68.5%
Return on invested capital
10.3%
Return on capital employed
11.2%
Return on sales
24.3%
Dividend yield
3.1%
DPS
$9
Payout ratio
114.1%
AMGN stock price
How has the Amgen stock price performed over time
Intraday
0.71%
1 week
-2.04%
1 month
-8.47%
1 year
10.3%
YTD
0.65%
QTD
-10.03%
Financial performance
How have Amgen's revenue and profit performed over time
Revenue
$32.53B
Gross profit
$19.68B
Operating income
$6.22B
Net income
$4.23B
Gross margin
60.5%
Net margin
13%
The net margin has dropped by 54% year-on-year but it rose by 29% since the previous quarter
The net income has contracted by 44% YoY but it has grown by 35% from the previous quarter
The company's operating margin fell by 42% YoY and by 4.5% QoQ
AMGN's operating income is down by 30% year-on-year
Growth
What is Amgen's growth rate over time
Valuation
What is Amgen stock price valuation
P/E
36.74
P/B
20.7
P/S
4.79
EV/EBIT
26.2
EV/EBITDA
15.37
EV/Sales
6.37
The P/E is 55% above the 5-year quarterly average of 23.6 but 7% below the last 4 quarters average of 39.4
AMGN's EPS is down by 44% year-on-year but it is up by 35% since the previous quarter
The stock's price to book (P/B) is 28% less than its 5-year quarterly average of 28.7 and 23% less than its last 4 quarters average of 26.6
Amgen's equity has increased by 27% from the previous quarter
The revenue has grown by 21% year-on-year and by 5% since the previous quarter
The P/S is 10% less than the 5-year quarterly average of 5.3 and 10% less than the last 4 quarters average of 5.3
Efficiency
How efficient is Amgen business performance
AMGN's return on assets has dropped by 50% year-on-year but it is up by 32% since the previous quarter
The ROE has contracted by 47% YoY but it has grown by 36% from the previous quarter
AMGN's return on sales is down by 42% year-on-year but it is up by 11% since the previous quarter
The ROIC has contracted by 39% YoY but it has grown by 16% from the previous quarter
Dividends
What is AMGN's dividend history
DPS
$9
Dividend yield
3.1%
Payout ratio
114.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Amgen financials performed over time
Amgen's total assets is 9% more than its total liabilities
AMGN's quick ratio has dropped by 67% year-on-year but it is up by 7% since the previous quarter
Amgen's current ratio has plunged by 54% YoY but it has increased by 4.8% from the previous quarter
Amgen's equity has increased by 27% from the previous quarter
AMGN's debt to equity is down by 24% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.